ACHE and Alzheimer disease: We considered both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) due to their physiological roles as therapeutic targets involved in the symptoms of Alzheimer’s disease, in the treatment of which the currently available drugs are AChE inhibitors.